Search Results for "Micronase"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Micronase. Results 11 to 13 of 13 total matches.
See also: glyburide
Saxagliptin (Onglyza) for Type 2 Diabetes
The Medical Letter on Drugs and Therapeutics • Nov 02, 2009 (Issue 1324)
, 2.5, 5 mg tabs 5-20 mg PO once or divided
8
17.70
DiaBeta (Sanofi-aventis) 35.70
Micronase (Pfizer ...
Saxagliptin (Onglyza - Bristol-Myers Squibb), the second oral dipeptidyl peptidase-4 (DPP-4) inhibitor to be marketed in the US, has been approved by the FDA for treatment of adults with type 2 diabetes.
Liraglutide (Victoza) for Type 2 Diabetes
The Medical Letter on Drugs and Therapeutics • Apr 05, 2010 (Issue 1335)
once or divided
7
11.99
DiaBeta (Sanofi-aventis) 42.76
Micronase (Pfizer) 44.99
micronized tablets ...
Liraglutide (Victoza – Novo Nordisk), a glucagon-like peptide-1 (GLP-1) receptor agonist given by subcutaneous
injection, has been approved by the FDA for treatment of patients with type 2 diabetes. It can be used alone or in addition to oral antidiabetic drugs such as metformin (Glucophage, and others) or glimepiride (Amaryl, and others). Liraglutide is not recommended for first-line therapy and is not approved for use with insulin.
Sitagliptin (Januvia) for Type 2 Diabetes
The Medical Letter on Drugs and Therapeutics • Jan 01, 2007 (Issue 1251)
DiaBeta (Aventis) 26.10
Micronase (Pfizer) 34.20
micronized tablets – generic 1.5, 3, 6 mg tabs 3 to 12 ...
Sitagliptin phosphate (Januvia - Merck) is the first dipeptidyl-peptidase-4 (DPP-4) inhibitor to be marketed for treatment of type 2 diabetes. It has been approved by the FDA for oral use as monotherapy or in combination with metformin (Glucophage, and others), pioglitazone (Actos) or rosiglitazone (Avandia).